Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Alimentary pharmacology and therapeutics

Results: 76-100/1697

Authors: Fitzgerald, AJ Jordinson, M Rhodes, JM Singh, R Calam, J Goodlad, RA
Citation: Aj. Fitzgerald et al., Comparison of the effects of concanavalin-A and epidermal growth factor onepithelial cell proliferation in the rat intestine, ALIM PHARM, 15(7), 2001, pp. 1077-1084

Authors: Neal, K Logan, R
Citation: K. Neal et R. Logan, Potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors, ALIM PHARM, 15(7), 2001, pp. 1085-1085

Authors: Laine, L
Citation: L. Laine, Reply - potential gastrointestinal effects of longterm acid suppression with proton pump inhibitors, ALIM PHARM, 15(7), 2001, pp. 1085-1086

Authors: Ahmad, T Satsangi, J Mcgovern, D Bunce, M Jewell, DP
Citation: T. Ahmad et al., Review Article: The genetics of inflammatory bowel disease, ALIM PHARM, 15(6), 2001, pp. 731-748

Authors: Schiller, LR
Citation: Lr. Schiller, Review Article: The therapy of constipation, ALIM PHARM, 15(6), 2001, pp. 749-763

Authors: Jones, R Bytzer, P
Citation: R. Jones et P. Bytzer, Review Article: Acid suppression in the management of gastro-oesophageal reflux disease - an appraisal of treatment options in primary care, ALIM PHARM, 15(6), 2001, pp. 765-772

Authors: Wingate, D Phillips, SF Lewis, SJ Malagelada, JR Speelman, P Steffen, R Tytgat, GNJ
Citation: D. Wingate et al., Guidelines for adults on self-medication for the treatment of acute diarrhoea, ALIM PHARM, 15(6), 2001, pp. 773-782

Authors: Schoon, EJ Geerling, BG Van Dooren, IMA Schurgers, LJ Vermeer, C Brummer, RJM Stockbrugger, RW
Citation: Ej. Schoon et al., Abnormal bone turnover in long-standing Crohn's disease in remission, ALIM PHARM, 15(6), 2001, pp. 783-792

Authors: Horai, Y Kimura, M Furuie, H Matsuguma, K Irie, S Koga, Y Nagahama, T Murakami, M Matsui, T Yao, T Urae, A Ishizaki, T
Citation: Y. Horai et al., Pharmacodynamic effects and kinetic disposition of rabeprazole in relationto CYP2C19 genotypes, ALIM PHARM, 15(6), 2001, pp. 793-803

Authors: Azuma, T Ito, Y Suto, H Ohtani, M Dojo, M Muramatsu, A Kuriyama, M Kato, T
Citation: T. Azuma et al., The effect of Helicobacter pylori eradication therapy on dyspepsia symptoms in industrial workers in Japan, ALIM PHARM, 15(6), 2001, pp. 805-811

Authors: Koike, T Ohara, S Sekine, H Iijima, K Kato, K Toyota, T Shimosegawa, T
Citation: T. Koike et al., Increased gastric acid secretion after Helicobacter pylori eradication maybe a factor for developing reflux oesophagitis, ALIM PHARM, 15(6), 2001, pp. 813-820

Authors: Capurso, G Annibale, B Osborn, J D'Ambra, G Martino, G Lahner, E Delle Fave, G
Citation: G. Capurso et al., Occurrence and relapse of bleeding from duodenal ulcer: respective roles of acid secretion and Helicobacter pylori infection, ALIM PHARM, 15(6), 2001, pp. 821-829

Authors: Fischbach, LA Correa, P Ramirez, H Realpe, JL Collazos, T Ruiz, B Bravo, LE Bravo, JC Casabon, AL Schmidt, BA
Citation: La. Fischbach et al., Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer, ALIM PHARM, 15(6), 2001, pp. 831-841

Authors: Wong, BCY Wang, WH Wong, WM Lau, GKK Fung, FMY Kung, NNS Chu, KM Lai, KC Hu, WHC Hu, FL Liu, XG Chan, CK Yuen, MF Hui, WM Lam, SK
Citation: Bcy. Wong et al., Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study, ALIM PHARM, 15(6), 2001, pp. 843-849

Authors: Meier, R Wettstein, A Drewe, J Geiser, HR
Citation: R. Meier et al., Fish oil (Eicosapen) is less effective than metronidazole, in combination with pantoprazole and clarithromycin, for Helicobacter pylori eradication, ALIM PHARM, 15(6), 2001, pp. 851-855

Authors: Matrella, E Valatas, V Notas, G Roumpaki, H Xidakis, C Hadzidakis, A Mouzas, I Kouroumalis, E
Citation: E. Matrella et al., Bolus somatostatin but not octreotide reduces hepatic sinusoidal pressure by a NO-independent mechanism in chronic liver disease, ALIM PHARM, 15(6), 2001, pp. 857-864

Authors: Naito, Y Takagi, T Matsuyama, K Yoshida, N Yoshikawa, T
Citation: Y. Naito et al., Pioglitazone, a specific PPAR-gamma ligand, inhibits aspirin-induced gastric mucosal injury in rats, ALIM PHARM, 15(6), 2001, pp. 865-873

Authors: Xiao, F Furuta, T Takashima, M Shirai, N Hanai, H
Citation: F. Xiao et al., Involvement of cyclooxygenase-2 in hyperplastic gastritis induced by Helicobacter pylori infection in C57BL/6 mice, ALIM PHARM, 15(6), 2001, pp. 875-886

Authors: Parkes, M Jewell, DP
Citation: M. Parkes et Dp. Jewell, Review article: the management of severe Crohn's disease, ALIM PHARM, 15(5), 2001, pp. 563-573

Authors: Helmy, AT Hayes, PC
Citation: At. Helmy et Pc. Hayes, Review article: current endoscopic therapeutic options in the management of variceal bleeding, ALIM PHARM, 15(5), 2001, pp. 575-594

Authors: Curry, JI Lander, TD Stringer, MD
Citation: Ji. Curry et al., Review article: erythromycin as a prokinetic agent in infants and children, ALIM PHARM, 15(5), 2001, pp. 595-603

Authors: Toledo, TK DiPalma, JA
Citation: Tk. Toledo et Ja. Dipalma, Review article: colon cleansing preparation for gastrointestinal procedures, ALIM PHARM, 15(5), 2001, pp. 605-611

Authors: Janssen, MJR Van Oijen, AHAM Verbeek, ALM Jansen, JBMJ De Boer, WA
Citation: Mjr. Janssen et al., A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ranitidine bismuth citrate plusclarithromycin and either amoxicillin or a nitroimidazole, ALIM PHARM, 15(5), 2001, pp. 613-624

Authors: Hawkes, ND Richardson, C Evans, BK Rhodes, J Lewis, SJ Thomas, GAO
Citation: Nd. Hawkes et al., Effect of an enteric-release formulation of naloxone on intestinal transitin volunteers taking codeine, ALIM PHARM, 15(5), 2001, pp. 625-630

Authors: Arguedas, MR Heudebert, GR Wilcox, CM
Citation: Mr. Arguedas et al., Surveillance colonoscopy or chemoprevention with COX-2 inhibitors in average-risk post-polypectomy patients: a decision analysis, ALIM PHARM, 15(5), 2001, pp. 631-638
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>